Spectrum Advisory Services’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Spectrum Advisory Services’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,800	Closed	-$281K	–	159
2015 Q2	$281K	Sell	6,800 -700	-9%	-$25.1K	0.11%	129
2015 Q1	$264K	Hold	7,500	–	–	0.09%	142
2014 Q4	$241K	Hold	7,500	–	–	0.08%	151
2014 Q3	$210K	Sell	7,500 -400	-5%	-$12.2K	0.08%	157
2014 Q2	$239K	Sell	7,900 -400	-5%	-$11K	0.08%	152
2014 Q1	$230K	Sell	8,300 -600	-7%	-$15.7K	0.08%	155
2013 Q4	$227K	Sell	8,900 -700	-7%	-$21.6K	0.08%	156
2013 Q3	$287K	Sell	9,600 -400	-4%	-$11.1K	0.11%	138
2013 Q2	$288K	Buy	+10,000	New	+$276K	0.12%	134

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Spectrum Advisory Services's BRLI Position: Q3 2015 in Review

Spectrum Advisory Services sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 6,800 shares — an estimated $281K sold.

Spectrum Advisory Services first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $288K in Q2 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Spectrum Advisory Services reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Spectrum Advisory Services sold 6,800 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $281K.
Spectrum Advisory Services first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Spectrum Advisory Services's BIO-REFERENCE LABS INC-NEW- position peaked at $288K in Q2 2013.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Spectrum Advisory Services's 13F filing for Q3 2015, filed 16 Nov 2015.